Artificial intelligence, or AI, is rapidly transforming the world of medicine. AI computers are diagnosing medical conditions at a rate equal to or better than humans, all while developing their own code and algorithms to do so. With the rise of AI, there are new issues of patentability, inventorship, and ownership that must be addressed. In this podcast, Finnegan partner Susan Tull discusses current issues surrounding intellectual property and AI in medicine.
To listen to the podcast click here
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.